Thus, the demonstrated molecular mechanism suggests a potential therapeutic strategy to improve the resolution of atherosclerosis after lipid lowering, namely, by co-activation of the IL-4 and PGE2 pathways in plaque macrophages. This evidence concerns the gene IL4 and atherosclerosis.